NCT00003737 Rebeccamycin Analog in Treating Children With Relapsed or Refractory Neuroblastoma Status COMPLETED Phase PHASE2
NCT00003667 Combination Chemotherapy and Biological Therapy in Treating Patients With High-Risk Ewing's Sarcoma Status COMPLETED Phase PHASE2
NCT00003659 Fludarabine, Cyclophosphamide, and Rituximab in Treating Patients Who Have Chronic Lymphocytic Leukemia Status COMPLETED Phase PHASE2
NCT00003658 Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Other B-cell Cancers Status COMPLETED Phase PHASE2
NCT00003632 Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Central Nervous System Lymphoma Status COMPLETED Phase PHASE2
NCT00003631 Chemotherapy Plus Radiation Therapy in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma Status COMPLETED Phase PHASE2
NCT00003630 Arsenic Trioxide in Treating Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00003544 Irinotecan in Treating Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00003543 Monoclonal Antibody Therapy Plus Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer Status COMPLETED Phase PHASE1
NCT00003542 Interferon Alfa in Treating Patients With Advanced Kidney Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00003541 Combination Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT00003540 Gemcitabine in Treating Women With Metastatic Breast Cancer Previously Treated With Doxorubicin and Paclitaxel Status COMPLETED Phase PHASE2
NCT00003539 Paclitaxel Plus Monoclonal Antibody Therapy in Treating Women With Recurrent or Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00003443 Bryostatin 1 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00003430 L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors Status COMPLETED Phase PHASE1
NCT00003429 PET Scans in Diagnosing Primary or Recurrent Cervical Cancer in Patients Who Are Undergoing Surgery Status COMPLETED Phase NA
NCT00003427 Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer Status COMPLETED Phase PHASE1
NCT00003426 Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT00003395 Arsenic Trioxide in Treating Patients With Advanced Hematologic Cancer Status COMPLETED Phase PHASE1